MASROOR AHMED M.D.
Prescription History 1861691081
Anesthesiology - Pain Medicine in Houston, TX

NPI Status: Active since July 17, 2007

Contact Information

11790 FM 1960 RD W
HOUSTON, TX
ZIP 77065
Phone: (281) 970-0500
Fax: (281) 970-0506

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MASROOR AHMED M.D., an active Pain Medicine specialist practicing in Houston, TX. Our medical registry currently tracks 26 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,186 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydrocodone-Acetaminophen, which accounts for 649 claims alone.


Acetaminophen-Codeine

Generic Formulation: Acetaminophen With CodeineSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 177
30-Day Fills 177.0
Days Supply 3,666
TX State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills44.7
Peer Average Days Supply736
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 302.3% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,570.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.82

State Avg Cost Per Claim

$18.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. This combination medication is used to help relieve mild to moderate pain. It contains an opioid pain reliever (codeine) and a non-opioid pain reliever (acetaminophen). Codeine works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Baclofen

Generic Formulation: BaclofenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 17
30-Day Fills 25.0
Days Supply 740
TX State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills55.5
Peer Average Days Supply1,537
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.5% less volume than the regional standard for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $210.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.40

State Avg Cost Per Claim

$27.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Belbuca

Generic Formulation: Buprenorphine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 37
30-Day Fills 37.0
Days Supply 1,057
TX State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills40.9
Peer Average Days Supply1,190
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $16,651.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$450.04

State Avg Cost Per Claim

$738.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.

Therapeutic Applications

Buprenorphine is used to help relieve severe ongoing pain. Buprenorphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use this medication to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Buprenorphine

Generic Formulation: BuprenorphineSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 54
30-Day Fills 54.0
Days Supply 1,556
TX State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills39.1
Peer Average Days Supply1,096
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 42.1% more claims than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $12,734.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$235.83

State Avg Cost Per Claim

$341.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.

Therapeutic Applications

This medication is used to help relieve severe ongoing pain (such as due to arthritis, chronic back pain). Buprenorphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (7.5, 10, 15, or 20 micrograms per hour patches) should be used only if you have been regularly taking moderate amounts of opioid pain medication. These strengths may cause overdose (even death) if used by a person who has not been regularly taking opioids. Do not use this medication to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Carisoprodol

Generic Formulation: CarisoprodolSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
TX State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills26.3
Peer Average Days Supply747
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.0% less volume than the regional standard for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $296.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.67

State Avg Cost Per Claim

$15.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)

Therapeutic Applications

Carisoprodol is used short-term to treat muscle pain and discomfort. It is usually used along with rest, physical therapy, and other treatments. It works by helping to relax the muscles.

Cyclobenzaprine Hcl

Generic Formulation: Cyclobenzaprine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 40
30-Day Fills 40.0
Days Supply 1,055
TX State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills45.1
Peer Average Days Supply1,173
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $113.12 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.83

State Avg Cost Per Claim

$16.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Diclofenac Sodium

Generic Formulation: Diclofenac SodiumSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 34
30-Day Fills 40.3
Days Supply 986
TX State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills55.2
Peer Average Days Supply1,335
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,818.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$53.48

State Avg Cost Per Claim

$35.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Therapeutic Applications

See also Warning section. This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain.

Famotidine

Generic Formulation: FamotidineSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 20
30-Day Fills 22.0
Days Supply 660
TX State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills39.0
Peer Average Days Supply831
Conservative Utilization

This provider writes prescriptions for this formulation 48.7% less frequently than the standard regional baseline metric for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $98.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.92

State Avg Cost Per Claim

$3.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Therapeutic Applications

Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist.

Fentanyl

Generic Formulation: FentanylSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 37
30-Day Fills 37.0
Days Supply 1,075
TX State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills39.4
Peer Average Days Supply1,140
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,162.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$58.46

State Avg Cost Per Claim

$112.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

Therapeutic Applications

This medication is used to help relieve severe ongoing pain (such as due to cancer). Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use the patch form of fentanyl to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Gabapentin

Generic Formulation: GabapentinSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 124
30-Day Fills 130.0
Days Supply 3,900
TX State Average Benchmarks
Peer Average Claims94.0
Peer Average 30-Day Fills159.7
Peer Average Days Supply4,701
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 31.9% more claims than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,751.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.19

State Avg Cost Per Claim

$21.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 649
30-Day Fills 649.0
Days Supply 15,717
TX State Average Benchmarks
Peer Average Claims121.0
Peer Average 30-Day Fills121.4
Peer Average Days Supply2,775
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 436.4% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $12,204.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.80

State Avg Cost Per Claim

$24.84

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Hydrocodone-Ibuprofen

Generic Formulation: Hydrocodone/IbuprofenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 278
TX State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills15.8
Peer Average Days Supply441
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,252.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$96.38

State Avg Cost Per Claim

$136.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used for a short time (usually less than 10 days) to help relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a nonsteroidal anti-inflammatory drug-NSAID (ibuprofen). Hydrocodone works in the brain to change how your body feels and responds to pain. Ibuprofen reduces pain and fever. This medication is not intended to treat long-term conditions (such as arthritis).

Hydromorphone Hcl

Generic Formulation: Hydromorphone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 622
TX State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills28.0
Peer Average Days Supply215
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $268.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.20

State Avg Cost Per Claim

$105.60

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An opioid analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Hydromorphone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Lidocaine

Generic Formulation: LidocaineSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 38
30-Day Fills 42.2
Days Supply 1,106
TX State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills36.2
Peer Average Days Supply1,002
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 26.7% more claims than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,261.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$85.82

State Avg Cost Per Claim

$138.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.

Therapeutic Applications

This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.

Methadone Hcl

Generic Formulation: Methadone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 49
30-Day Fills 49.0
Days Supply 1,355
TX State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills40.6
Peer Average Days Supply1,164
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $701.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.32

State Avg Cost Per Claim

$19.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)

Therapeutic Applications

This medication is used to treat addiction to opioids (such as heroin) as part of an approved treatment program. Methadone belongs to a class of drugs known as opioid analgesics. It helps prevent withdrawal symptoms caused by stopping other opioids.

Methocarbamol

Generic Formulation: MethocarbamolSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 340
TX State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills35.3
Peer Average Days Supply844
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.8% less volume than the regional standard for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $144.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.29

State Avg Cost Per Claim

$13.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)

Therapeutic Applications

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Morphine Sulfate

Generic Formulation: Morphine SulfateSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 84
30-Day Fills 84.0
Days Supply 1,959
TX State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills33.1
Peer Average Days Supply811
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 154.5% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,041.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.30

State Avg Cost Per Claim

$34.84

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Therapeutic Applications

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Morphine Sulfate Er

Generic Formulation: Morphine SulfateSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 108
30-Day Fills 108.0
Days Supply 3,240
TX State Average Benchmarks
Peer Average Claims61.0
Peer Average 30-Day Fills61.1
Peer Average Days Supply1,764
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 77.0% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,035.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$28.10

State Avg Cost Per Claim

$41.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Therapeutic Applications

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 44
30-Day Fills 44.0
Days Supply 1,282
TX State Average Benchmarks
Peer Average Claims57.0
Peer Average 30-Day Fills57.3
Peer Average Days Supply1,262
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $734.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.70

State Avg Cost Per Claim

$25.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 31
30-Day Fills 31.0
Days Supply 851
TX State Average Benchmarks
Peer Average Claims76.0
Peer Average 30-Day Fills76.9
Peer Average Days Supply1,854
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 59.2% less volume than the regional standard for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $566.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.29

State Avg Cost Per Claim

$30.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Pregabalin

Generic Formulation: PregabalinSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 74
30-Day Fills 80.0
Days Supply 2,400
TX State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills64.4
Peer Average Days Supply1,896
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 54.2% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,656.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.38

State Avg Cost Per Claim

$43.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Ropinirole Hcl

Generic Formulation: Ropinirole HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 116
30-Day Fills 132.2
Days Supply 3,957
TX State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills56.8
Peer Average Days Supply1,674
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 286.7% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,437.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.39

State Avg Cost Per Claim

$21.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to treat Parkinson's disease. It can improve your ability to move and decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move (on-off syndrome). Ropinirole works by helping to restore the balance of a certain natural substance (dopamine) in the brain.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 179
30-Day Fills 181.0
Days Supply 4,811
TX State Average Benchmarks
Peer Average Claims55.0
Peer Average 30-Day Fills72.3
Peer Average Days Supply1,936
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 225.5% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,374.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.68

State Avg Cost Per Claim

$14.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 143
30-Day Fills 143.0
Days Supply 3,359
TX State Average Benchmarks
Peer Average Claims62.0
Peer Average 30-Day Fills63.6
Peer Average Days Supply1,282
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 130.6% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,324.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.27

State Avg Cost Per Claim

$7.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Tramadol Hcl-Acetaminophen

Generic Formulation: Tramadol Hcl/AcetaminophenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 157
TX State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills32.6
Peer Average Days Supply551
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 65.6% less volume than the regional standard for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $266.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.19

State Avg Cost Per Claim

$21.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. This product is used to treat moderate to moderately severe pain. It contains 2 medications: tramadol and acetaminophen. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Acetaminophen is used to relieve pain, and it can also reduce a fever.

Xtampza Er

Generic Formulation: Oxycodone MyristateSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 57
30-Day Fills 57.0
Days Supply 1,706
TX State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills44.2
Peer Average Days Supply1,261
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 29.5% more claims than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $28,674.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$503.06

State Avg Cost Per Claim

$639.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to help relieve severe ongoing pain (such as due to cancer). Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Higher doses of this drug (more than 36 milligrams per dose or 72 milligrams per day) should be used only if you have been regularly taking moderate to large amounts of an opioid medication. These doses may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of oxycodone to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MASROOR AHMED M.D. provides transparency into local medical care patterns within Houston, TX.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pain Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.